RLACX Mutual Fund

NAV$30.02

Fund Essentials - as of Jan 31, 2026

Net Assets
$16M
Expense Ratio
1.36%
Dividend Yield (Current)
7.09%
Holdings
1,119
Inception Date
Sep 2, 2008
Fund Family
Russell Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+23.39%
1 Year+39.66%
3 Year+15.11%
5 Year+6.63%
10 Year+10.71%

Asset Allocation

Stocks: 94.78%
Cash: 5.10%
Other: 0.12%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
-U.s. Cash Management Fund5.09%
LGNDLigand Pharmaceuticals, Inc.0.72%
AGXArgan, Inc.0.64%
WTTRSelect Energy Services Inc0.62%
BBIOBridgebio Pharma Inc0.57%
Top 10 Concentration: 10.36%Report Date: Jan 31, 2026
Download all 1119 holdings for RLACX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.09%
Frequency
Annually
Latest Distribution
$9.23
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how RLACX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

RLACX Mutual Fund Overview

RLACX Mutual Fund (Russell US Small Cap Equity Fund Class A) is managed by Russell Investments with $15.8M in net assets. RLACX expense ratio is 1.36%, holding 1119 positions across sectors including Industrials, Financials, Health Care. Inception date: 2008-09-02.

RLACX performance shows a YTD return of 23.39%. The 1-year return is 39.66% and the 5-year return is 6.63%. RLACX dividend yield stands at 7.09%, paid annually.

RLACX top holdings include U.s. Cash Management Fund (5.1%), Ligand Pharmaceuticals, Inc. (0.7%), Argan, Inc. (0.6%), Select Energy Services Inc (0.6%), Bridgebio Pharma Inc (0.6%). View all RLACX holdings, sector breakdown, or dividend history.

RLACX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RLACX alternatives are available via the screener, along with tax-loss harvesting opportunities.